Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population
Objective To test if patients recovering from COVID-19 are at increased risk of mental morbidities and to what extent such risk is exacerbated by illness severity.Design Population-based cross-sectional study.Setting Iceland.Participants A total of 22 861 individuals were recruited through invitatio...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/11/7/e049967.full |
id |
doaj-f36ccaf95f204268b4fcc6ea55637fc1 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Unnur Valdimarsdottir Thor Aspelund Gunnar Tomasson Thorvardur Jon Love Elias Eythorsson Runolfur Palsson Gudrun Petursdottir Arna Hauksdottir Gunnar Gudmundsson Karen Sól Saevarsdóttir Hildur Ýr Hilmarsdóttir Ingibjörg Magnúsdóttir Edda Bjork Thordardottir Ásdís Braga Gudjónsdóttir Harpa Rúnarsdóttir Harpa Lind Jónsdóttir Berglind Gudmundsdóttir Pétur Henry Petersen Sigurdur Yngvi Kristinsson Sif Hansdóttir Hrönn Hardardóttir Dóra Gudrún Gudmundsdóttir Hildur Sigbjörnsdóttir Sigrídur Haraldsdóttir Alma Dagbjört Möller Jóhanna Jakobsdóttir |
spellingShingle |
Unnur Valdimarsdottir Thor Aspelund Gunnar Tomasson Thorvardur Jon Love Elias Eythorsson Runolfur Palsson Gudrun Petursdottir Arna Hauksdottir Gunnar Gudmundsson Karen Sól Saevarsdóttir Hildur Ýr Hilmarsdóttir Ingibjörg Magnúsdóttir Edda Bjork Thordardottir Ásdís Braga Gudjónsdóttir Harpa Rúnarsdóttir Harpa Lind Jónsdóttir Berglind Gudmundsdóttir Pétur Henry Petersen Sigurdur Yngvi Kristinsson Sif Hansdóttir Hrönn Hardardóttir Dóra Gudrún Gudmundsdóttir Hildur Sigbjörnsdóttir Sigrídur Haraldsdóttir Alma Dagbjört Möller Jóhanna Jakobsdóttir Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population BMJ Open |
author_facet |
Unnur Valdimarsdottir Thor Aspelund Gunnar Tomasson Thorvardur Jon Love Elias Eythorsson Runolfur Palsson Gudrun Petursdottir Arna Hauksdottir Gunnar Gudmundsson Karen Sól Saevarsdóttir Hildur Ýr Hilmarsdóttir Ingibjörg Magnúsdóttir Edda Bjork Thordardottir Ásdís Braga Gudjónsdóttir Harpa Rúnarsdóttir Harpa Lind Jónsdóttir Berglind Gudmundsdóttir Pétur Henry Petersen Sigurdur Yngvi Kristinsson Sif Hansdóttir Hrönn Hardardóttir Dóra Gudrún Gudmundsdóttir Hildur Sigbjörnsdóttir Sigrídur Haraldsdóttir Alma Dagbjört Möller Jóhanna Jakobsdóttir |
author_sort |
Unnur Valdimarsdottir |
title |
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population |
title_short |
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population |
title_full |
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population |
title_fullStr |
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population |
title_full_unstemmed |
Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic population |
title_sort |
illness severity and risk of mental morbidities among patients recovering from covid-19: a cross-sectional study in the icelandic population |
publisher |
BMJ Publishing Group |
series |
BMJ Open |
issn |
2044-6055 |
publishDate |
2021-07-01 |
description |
Objective To test if patients recovering from COVID-19 are at increased risk of mental morbidities and to what extent such risk is exacerbated by illness severity.Design Population-based cross-sectional study.Setting Iceland.Participants A total of 22 861 individuals were recruited through invitations to existing nationwide cohorts and a social media campaign from 24 April to 22 July 2020, of which 373 were patients recovering from COVID-19.Main outcome measures Symptoms of depression (Patient Health Questionnaire), anxiety (General Anxiety Disorder Scale) and posttraumatic stress disorder (PTSD; modified Primary Care PTSD Screen for DSM-5) above screening thresholds. Adjusting for multiple covariates and comorbidities, multivariable Poisson regression was used to assess the association between COVID-19 severity and mental morbidities.Results Compared with individuals without a diagnosis of COVID-19, patients recovering from COVID-19 had increased risk of depression (22.1% vs 16.2%; adjusted relative risk (aRR) 1.48, 95% CI 1.20 to 1.82) and PTSD (19.5% vs 15.6%; aRR 1.38, 95% CI 1.09 to 1.75) but not anxiety (13.1% vs 11.3%; aRR 1.24, 95% CI 0.93 to 1.64). Elevated relative risks were limited to patients recovering from COVID-19 that were 40 years or older and were particularly high among individuals with university education. Among patients recovering from COVID-19, symptoms of depression were particularly common among those in the highest, compared with the lowest tertile of influenza-like symptom burden (47.1% vs 5.8%; aRR 6.42, 95% CI 2.77 to 14.87), among patients confined to bed for 7 days or longer compared with those never confined to bed (33.3% vs 10.9%; aRR 3.67, 95% CI 1.97 to 6.86) and among patients hospitalised for COVID-19 compared with those never admitted to hospital (48.1% vs 19.9%; aRR 2.72, 95% CI 1.67 to 4.44).Conclusions Severe disease course is associated with increased risk of depression and PTSD among patients recovering from COVID-19. |
url |
https://bmjopen.bmj.com/content/11/7/e049967.full |
work_keys_str_mv |
AT unnurvaldimarsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT thoraspelund illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT gunnartomasson illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT thorvardurjonlove illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT eliaseythorsson illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT runolfurpalsson illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT gudrunpetursdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT arnahauksdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT gunnargudmundsson illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT karensolsaevarsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT hilduryrhilmarsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT ingibjorgmagnusdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT eddabjorkthordardottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT asdisbragagudjonsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT harparunarsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT harpalindjonsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT berglindgudmundsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT peturhenrypetersen illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT sigurduryngvikristinsson illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT sifhansdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT hronnhardardottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT doragudrungudmundsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT hildursigbjornsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT sigridurharaldsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT almadagbjortmoller illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation AT johannajakobsdottir illnessseverityandriskofmentalmorbiditiesamongpatientsrecoveringfromcovid19acrosssectionalstudyintheicelandicpopulation |
_version_ |
1721217005020774400 |
spelling |
doaj-f36ccaf95f204268b4fcc6ea55637fc12021-08-07T16:33:33ZengBMJ Publishing GroupBMJ Open2044-60552021-07-0111710.1136/bmjopen-2021-049967Illness severity and risk of mental morbidities among patients recovering from COVID-19: a cross-sectional study in the Icelandic populationUnnur Valdimarsdottir0Thor Aspelund1Gunnar Tomasson2Thorvardur Jon Love3Elias Eythorsson4Runolfur Palsson5Gudrun Petursdottir6Arna Hauksdottir7Gunnar Gudmundsson8Karen Sól Saevarsdóttir9Hildur Ýr Hilmarsdóttir10Ingibjörg Magnúsdóttir11Edda Bjork Thordardottir12Ásdís Braga Gudjónsdóttir13Harpa Rúnarsdóttir14Harpa Lind Jónsdóttir15Berglind Gudmundsdóttir16Pétur Henry Petersen17Sigurdur Yngvi Kristinsson18Sif Hansdóttir19Hrönn Hardardóttir20Dóra Gudrún Gudmundsdóttir21Hildur Sigbjörnsdóttir22Sigrídur Haraldsdóttir23Alma Dagbjört Möller24Jóhanna Jakobsdóttir25Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandLandspitali–The National University Hospital of Iceland, Reykjavik, IcelandLandspitali–The National University Hospital of Iceland, Reykjavik, IcelandLandspitali–The National University Hospital of Iceland, Reykjavik, IcelandInstitute for Sustainability Studies, University of Iceland, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandLandspitali–The National University Hospital of Iceland, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandFaculty of Medicine, University of Iceland School of Health Sciences, Reykjavik, IcelandFaculty of Medicine, University of Iceland School of Health Sciences, Reykjavik, IcelandLandspitali–The National University Hospital of Iceland, Reykjavik, IcelandLandspitali–The National University Hospital of Iceland, Reykjavik, IcelandLandspitali–The National University Hospital of Iceland, Reykjavik, IcelandThe Directorate of Health, Reykjavik, IcelandThe Directorate of Health, Reykjavik, IcelandThe Directorate of Health, Reykjavik, IcelandThe Directorate of Health, Reykjavik, IcelandCentre of Public Health Sciences, Faculty of Medicine, University of Iceland, School of Health Sciences, Reykjavik, IcelandObjective To test if patients recovering from COVID-19 are at increased risk of mental morbidities and to what extent such risk is exacerbated by illness severity.Design Population-based cross-sectional study.Setting Iceland.Participants A total of 22 861 individuals were recruited through invitations to existing nationwide cohorts and a social media campaign from 24 April to 22 July 2020, of which 373 were patients recovering from COVID-19.Main outcome measures Symptoms of depression (Patient Health Questionnaire), anxiety (General Anxiety Disorder Scale) and posttraumatic stress disorder (PTSD; modified Primary Care PTSD Screen for DSM-5) above screening thresholds. Adjusting for multiple covariates and comorbidities, multivariable Poisson regression was used to assess the association between COVID-19 severity and mental morbidities.Results Compared with individuals without a diagnosis of COVID-19, patients recovering from COVID-19 had increased risk of depression (22.1% vs 16.2%; adjusted relative risk (aRR) 1.48, 95% CI 1.20 to 1.82) and PTSD (19.5% vs 15.6%; aRR 1.38, 95% CI 1.09 to 1.75) but not anxiety (13.1% vs 11.3%; aRR 1.24, 95% CI 0.93 to 1.64). Elevated relative risks were limited to patients recovering from COVID-19 that were 40 years or older and were particularly high among individuals with university education. Among patients recovering from COVID-19, symptoms of depression were particularly common among those in the highest, compared with the lowest tertile of influenza-like symptom burden (47.1% vs 5.8%; aRR 6.42, 95% CI 2.77 to 14.87), among patients confined to bed for 7 days or longer compared with those never confined to bed (33.3% vs 10.9%; aRR 3.67, 95% CI 1.97 to 6.86) and among patients hospitalised for COVID-19 compared with those never admitted to hospital (48.1% vs 19.9%; aRR 2.72, 95% CI 1.67 to 4.44).Conclusions Severe disease course is associated with increased risk of depression and PTSD among patients recovering from COVID-19.https://bmjopen.bmj.com/content/11/7/e049967.full |